Completed PHASE2 INTERVENTIONAL 1-arm NCT01075399

Study of [F 18]HX4 Positron Emission Tomography (PET) as a Tool to Detect Hypoxia in Tumors (HX4-200)

A Pilot, Phase II , Open Label, Nonrandomized, Multi- Center Study of [F 18]HX4 Positron Emission Tomography (PET) to Detect Hypoxia in Tumors

Sponsor: Siemens Molecular Imaging

Conditions Cervical Cancer Head and Neck Cancer Liver Cancer Lung Cancer Rectal Cancer

Interventions [F 18]HX4

Updated 8 times since 2017 Last updated: Jul 26, 2013 Started: Feb 28, 2010 Primary completion: May 31, 2011 Completion: Feb 29, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Cervical Cancer and Head and Neck Cancer, this trial is completed. The trial is conducted by Siemens Molecular Imaging and has accumulated 8 data snapshots since 2010. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2023 — Jul 2024 [monthly]

Completed PHASE2
Dec 2022 — Jan 2023 [monthly]

Completed PHASE2
Jan 2021 — Dec 2022 [monthly]

Completed PHASE2

▶ Show 3 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Feb 2017 — Jun 2018 [monthly]

Completed PHASE2
Jan 2017 — Feb 2017 [monthly]

Completed PHASE2

First recorded

Feb 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Siemens Molecular Imaging

Data source: Siemens Molecular Imaging

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.